tx 3301 and telmisartan
tx 3301 has been researched along with telmisartan in 3 studies
Compound Research Comparison
| Studies (tx 3301) | Trials (tx 3301) | Recent Studies (post-2010) (tx 3301) | Studies (telmisartan) | Trials (telmisartan) | Recent Studies (post-2010) (telmisartan) |
|---|---|---|---|---|---|
| 69 | 15 | 16 | 1,930 | 480 | 1,038 |
Protein Interaction Comparison
| Protein | Taxonomy | tx 3301 (IC50) | telmisartan (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.42 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0179 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0003 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 0.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.2589 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8621 |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Diener, HC; Sacco, R; Yusuf, S | 1 |
Other Studies
3 other study(ies) available for tx 3301 and telmisartan
| Article | Year |
|---|---|
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine | 2003 |
[PRoFESS study presented. Change in secondary prevention].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors | 2003 |
Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Data Interpretation, Statistical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Telmisartan; Ticlopidine | 2008 |